• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 1
  • 1

PRICE

0
0
0
1

PUBLISHED

0
0
0
1

PRODUCT TYPE

1

Search "Insomnia Therapeutics - Pipeline Assessment and Market Forecasts to 2018" returned 1 results.

PRODUCT TITLE
Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt - Product Thumbnail Image

Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt

The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market...

July 2010
FROM
Loading Indicator